Latest News about BMY
Recent news which mentions BMY
Stocks That Hit 52-Week Highs On Thursday
April 07, 2022
From Benzinga
From Benzinga
Pfizer's $6.7 Billion Bet Could Be About to Pay Off Big Time
April 06, 2022
From Motley Fool
MindMed Appoints Francois Lilienthal As New CCO
April 05, 2022
From Benzinga
Bristol Myers Squibb Scores Three Back To Back European Approvals For Opdivo In Esophageal, Urothelial Cancer
April 05, 2022
Tickers
BMY
From Benzinga
2 Buffett Stocks That Are Great Buys in April
April 05, 2022
From Motley Fool
From Benzinga
7 Biotech Stocks to Buy With Key Catalysts for April
April 05, 2022
From InvestorPlace
Bristol Myers' Mavacamten Shows Sustained Improvements In Cardiovascular Outcomes In Cardiomyopathy Study
April 04, 2022
Tickers
BMY
From Benzinga
7 No-Brainer Stocks to Buy for April
April 04, 2022
From InvestorPlace
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
April 03, 2022
From Benzinga
2 Drugmakers Set for Explosive Revenue This Decade
April 03, 2022
From Motley Fool
From Benzinga
2 Warren Buffett Stocks to Buy Now and Hold Forever
March 31, 2022
From Motley Fool
Portage Biotech Shares Encouraging Preliminary Safety Data From Lead iNKT Agonists Program In Cancer Patients
March 31, 2022
From Benzinga
From Motley Fool
From InvestorPlace
2 Stocks Defying the Market Sell-Off Right Now
March 29, 2022
From Motley Fool
Which Chinese Stocks Will Be Delisted? 8 in U.S. Crosshairs
March 28, 2022
From InvestorPlace
From Benzinga
From Motley Fool
FDA Pushes Bristol Myers' Reblozyl Decision Date In Non-Transfusion Dependent Beta Thalassemia
March 25, 2022
Tickers
BMY
From Benzinga
The Daily Biotech Pulse: MEI Pharma Wilts On Adverse Regulatory Development, Decision Day For Zogenix, AN2 Therapeutics IPO
March 25, 2022
From Benzinga
Sunshine Biopharma's $8 Million Private Placement Injects New Funding For Drug Development
March 24, 2022
From Benzinga
From Benzinga
This Beaten-Down Dividend Stock Is Still a Buy
March 23, 2022
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.